These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11762028)

  • 1. [Chemotherapy for hepatocellular carcinoma].
    Okada S
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():645-9. PubMed ID: 11762028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of hepatocellular carcinoma].
    Okada S
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):2028-31. PubMed ID: 8586926
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma].
    Usui T; Shiozawa S; Kim DH; Tsuchiya A; Masuda T; Inose S; Aizawa M; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2702-4. PubMed ID: 21224685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for advanced hepatocellular carcinoma: systemic chemotherapy or hepatic arterial infusion chemotherapy?
    Yamashita T
    J Gastroenterol; 2004; 39(4):404-6. PubMed ID: 15168258
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy in hepatocellular carcinoma.
    Okada S
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1259-63. PubMed ID: 9730385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Targeting cancer chemotherapy used Lipiodol as a carrier].
    Konno T
    Nihon Rinsho; 1989 Jun; 47(6):1384-90. PubMed ID: 2549286
    [No Abstract]   [Full Text] [Related]  

  • 7. [Local, non-surgical treatment of hepatocellular carcinoma].
    Roche A
    Ann Chir; 1998; 52(1):75-8. PubMed ID: 9752414
    [No Abstract]   [Full Text] [Related]  

  • 8. Subselective intra-arterial chemotherapy infusion in the treatment of hepatocellular carcinoma.
    Daniels JR; Wallman M
    Semin Oncol; 2010 Apr; 37(2):83-8. PubMed ID: 20494699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatocellular carcinoma].
    Kondo S; Ueno H; Morizane C; Okusaka T
    Gan To Kagaku Ryoho; 2010 Jul; 37(7):1219-23. PubMed ID: 20647702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor-mediated protection of normal hepatocytes during chemotherapy for hepatocellular carcinoma.
    Keegan-Rogers V; Wu CH; Wu GY
    Targeted Diagn Ther; 1991; 4():105-25. PubMed ID: 1665717
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation.
    Kim R; El-Gazzaz G; Tan A; Elson P; Byrne M; Chang YD; Aucejo F
    Oncology; 2010; 79(1-2):62-6. PubMed ID: 21071991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional chemotherapy approaches for primary and metastatic liver tumors.
    Venook AP; Warren RS
    Surg Oncol Clin N Am; 1996 Apr; 5(2):411-427. PubMed ID: 9019361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver resection. I].
    Oldhafer KJ; Stavrou GA
    Zentralbl Chir; 2006 Oct; 131(5):W54-66; quiz W67-8. PubMed ID: 17089283
    [No Abstract]   [Full Text] [Related]  

  • 14. Out of control: hepatitis B reactivation by transarterial treatment of hepatocellular carcinoma.
    von Weizsäcker F; Blum HE
    J Hepatol; 2004 Sep; 41(3):482-4. PubMed ID: 15336452
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
    Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
    Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma.
    Nakashima K; Kitano S; Kim YI; Aramaki M; Kawano K
    Hepatogastroenterology; 1996; 43(12):1410-4. PubMed ID: 8975940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can adjuvant chemotherapy of hepatocellular carcinoma improve results of liver transplantation?].
    Burtin P
    Gastroenterol Clin Biol; 1993; 17(10):776-7. PubMed ID: 8288099
    [No Abstract]   [Full Text] [Related]  

  • 18. A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma.
    Woo HY; Bae SH; Park JY; Han KH; Chun HJ; Choi BG; Im HU; Choi JY; Yoon SK; Cheong JY; Cho SW; Jang BK; Hwang JS; Kim SG; Kim YS; Seo YS; Yim HJ; Um SH;
    Cancer Chemother Pharmacol; 2010 Jan; 65(2):373-82. PubMed ID: 19763572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma.
    Shao YY; Huang CC; Liang PC; Lin ZZ
    Asia Pac J Clin Oncol; 2010 Jun; 6(2):80-8. PubMed ID: 20565419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGE AFEF recommendations].
    Boige V; Barbare JC; Rosmorduc O;
    Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt. 1):3-7. PubMed ID: 18341970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.